These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 25530332)

  • 1. Herpes zoster (shingles) at a large New Zealand general practice: incidence over 5 years.
    Reid JS; Ah Wong B
    N Z Med J; 2014 Dec; 127(1407):56-60. PubMed ID: 25530332
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gender difference in the incidence of shingles.
    Fleming DM; Cross KW; Cobb WA; Chapman RS
    Epidemiol Infect; 2004 Jan; 132(1):1-5. PubMed ID: 14979582
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vaccination strategies for the prevention of herpes zoster and postherpetic neuralgia.
    Betts RF
    J Am Acad Dermatol; 2007 Dec; 57(6 Suppl):S143-7. PubMed ID: 18021866
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vaccination: a new option to reduce the burden of herpes zoster.
    Mick G
    Expert Rev Vaccines; 2010 Mar; 9(3 Suppl):31-5. PubMed ID: 20192716
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Possible association of lower rate of postherpetic neuralgia in patients on anti-tumor necrosis factor-α.
    Javed S; Kamili QU; Mendoza N; Tyring SK
    J Med Virol; 2011 Nov; 83(11):2051-5. PubMed ID: 21915882
    [TBL] [Abstract][Full Text] [Related]  

  • 6. No evidence of family history as a risk factor for herpes zoster in patients with post-herpetic neuralgia.
    Gatti A; Pica F; Boccia MT; De Antoni F; Sabato AF; Volpi A
    J Med Virol; 2010 May; 82(6):1007-11. PubMed ID: 20419815
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A population based study of the epidemiology of Herpes Zoster and its complications.
    Weitzman D; Shavit O; Stein M; Cohen R; Chodick G; Shalev V
    J Infect; 2013 Nov; 67(5):463-9. PubMed ID: 23872209
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical-epidemiological trends of herpes zoster: a 5-year study.
    Brănişteanu DE; Stoleriu G; Oanţă A; Dorobăţ CM; Petrariu FD; Anchidin DM; Ciubotaru FM; Brănişteanu DC
    Rev Med Chir Soc Med Nat Iasi; 2014; 118(3):817-22. PubMed ID: 25341306
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantifying the incidence and burden of herpes zoster in New Zealand general practice: a retrospective cohort study using a natural language processing software inference algorithm.
    Turner NM; MacRae J; Nowlan ML; McBain L; Stubbe MH; Dowell A
    BMJ Open; 2018 May; 8(5):e021241. PubMed ID: 29858420
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epidemiological features and costs of herpes zoster in Taiwan: a national study 2000 to 2006.
    Jih JS; Chen YJ; Lin MW; Chen YC; Chen TJ; Huang YL; Chen CC; Lee DD; Chang YT; Wang WJ; Liu HN
    Acta Derm Venereol; 2009 Nov; 89(6):612-6. PubMed ID: 19997693
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Herpes Zoster and its prevention in Italy. Scientific consensus statement].
    Franco E; Gabutti G; Bonanni P; Conversano M; Stefano Valente ME; Ferro A; Icardi G; Antonio Volpi ML; Maggi S; Rossi A; Scotti S; Vitale F; Greco D;
    Ig Sanita Pubbl; 2014; 70(1):111-27. PubMed ID: 24770367
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The burden of herpes zoster and postherpetic neuralgia in the United States.
    Weaver BA
    J Am Osteopath Assoc; 2007 Mar; 107(3 Suppl 1):S2-7. PubMed ID: 17488884
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevention of herpes zoster and its painful and debilitating complications.
    Johnson R; McElhaney J; Pedalino B; Levin M
    Int J Infect Dis; 2007 Nov; 11 Suppl 2():S43-8. PubMed ID: 18162246
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of S-LANSS, a tool for screening neuropathic pain, for predicting postherpetic neuralgia in patients after acute herpes zoster events: a single-center, 12-month, prospective cohort study.
    Cho SI; Lee CH; Park GH; Park CW; Kim HO
    J Pain; 2014 Feb; 15(2):149-56. PubMed ID: 24342706
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Herpes zoster in the Czech Republic--epidemiology and clinical manifestations].
    Smetana J; Salavec M; Bostíková V; Chlíbek R; Bostík P; Hanovcová I; Vacková M; Matulková P; Splino M
    Epidemiol Mikrobiol Imunol; 2010 Aug; 59(3):138-46. PubMed ID: 20925251
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel vaccine (Zostavax) to prevent herpes zoster and postherpetic neuralgia.
    Holcomb K; Weinberg JM
    J Drugs Dermatol; 2006 Oct; 5(9):863-6. PubMed ID: 17039651
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Herpes zoster ophthalmicus: comparison of disease in patients 60 years and older versus younger than 60 years.
    Ghaznawi N; Virdi A; Dayan A; Hammersmith KM; Rapuano CJ; Laibson PR; Cohen EJ
    Ophthalmology; 2011 Nov; 118(11):2242-50. PubMed ID: 21788078
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Management of herpes zoster (shingles) and postherpetic neuralgia.
    Stankus SJ; Dlugopolski M; Packer D
    Am Fam Physician; 2000 Apr; 61(8):2437-44, 2447-8. PubMed ID: 10794584
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Study tests Varicella-Zoster vaccine for over 60-years-old persons. Protection from Herpes zoster and postherpetic neuralgia].
    MMW Fortschr Med; 2006; Spec no.1():14-5. PubMed ID: 16872127
    [No Abstract]   [Full Text] [Related]  

  • 20. Identification of herpes zoster high-risk group using Charlson comorbidity index: A nationwide retrospective cohort study.
    Cho SI; Lee DH; Park YM
    J Dermatol; 2020 Jan; 47(1):47-53. PubMed ID: 31642113
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.